Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Traction Alopecia

Description

In a discussion about traction alopecia, the speaker thanks Dr. Antonella and outlines the condition as a secondary hair loss form due to repetitive tension on the hair shaft. It affects diverse ethnicities, particularly impacting up to one-third of adult African American women. Initially non-scarring and reversible, traction alopecia can become permanent if left untreated. The speaker identifies risk factors, including high-tension hairstyles, and emphasizes the importance of early detection via trichoscopy, which reveals signs of hair follicle damage. Treatment involves three key components: educating patients about minimizing tension, employing anti-inflammatory therapies such as corticosteroids, and medications like topical minoxidil to promote hair regrowth. The speaker showcases a successful case illustrating the benefits of patient education through trichoscopic images, enhancing treatment commitment. Additionally, the presentation touches on other treatments, including low-dose oral minoxidil and PRP (Platelet-Rich Plasma) therapy, though more research is needed for definitive recommendations. Finally, it suggests considering surgical options for patients with chronic cases, combining medical and surgical approaches for optimal outcomes.

View more

Conclusions

  • Tractional alopecia is a significant cause of hair loss particularly in individuals of African descent, affecting a large percentage of women and children.
  • It is characterized by reversible acute phases that can lead to permanent hair loss if tension persists over time.
  • Risk factors include high tension hairstyles such as braids, locks, and tight buns, which induce traction on the hair shaft.
  • Clinical examination and trichoscopy are essential for diagnosing and differentiating tractional alopecia from other hair loss disorders.
  • Treatment should focus on education to minimize traction, anti-inflammatory therapies, and stimulating hair regrowth with medications like minoxidil.
  • Topical and intralesional corticosteroids can effectively reduce inflammation associated with tractional alopecia.
  • Platelet-rich plasma (PRP) therapy shows some promise, although more studies are needed to establish its efficacy in treating tractional alopecia.
  • Surgical options, including hair transplantation, may be considered for patients with chronic cases of tractional alopecia that respond poorly to medical treatments.
  • Mirmirani P, Khumalo NP. Dermatol Clin. 2014 Apr;32(2):153-61.
  • Larrondo J, McMichael AJ. Traction Alopecia. JAMA Dermatol. 2023 Jun 1;159(6):676.
  • Uwakwe L, DeSouza B, Garza-Tovar, McMichael A. J Drugs Dermatol. 2020 Feb 1;19(2):128-130.
  • Akintilo L, Yin L, Svigos K, Kakpovbia E, Shapiro J, Sicco KL. J Drugs Dermatol. 2021 May 1;20(5):578-579.
  • Kim SR, Craiglow BG. JAAD Case Rep. 2022 Apr 1;23:112-113.
  • Awad A, Chim 1,Sharma P, Bhoyrul B. J Am Acad Dermatol.2023 Jul;89(1):157-159.
  • Larrondo J, Petela J, McMichael AJ. Dermatol Ther. 2022 Nov;35(11)